You are reading 1 of 2 free-access articles allowed for 30 days
In 2016, the largest single spend was €111,751, paid to NUI Galway for the commissioning and development of four national clinical guidelines.
The second-highest amount was received by Amárach Research. It was paid €96,125 for work it conducted on alcohol policy, with the “piloting of mock labels through targeted groups”. The third-highest amount (€55,081) was to Milliman Ltd for “actuarial, accounting, insurance and economic advice as and when required”.
In 2015, the highest payment was to DKM Economic Consultants Ltd, which received €144,587 for “analysis of potential measures to encourage provision of Nursing Home and Community Nursing unit facilities”.
Also in 2015, Indecon received €143,486 for its analysis of “potential measures to encourage provision of primary care facilities”.
Separately, the Department has spent more than €200,000 on two recently-completed reports relating to drugs strategy, according to new figures it has provided to MI.
The total cost of a report on the public consultation process around the new National Drugs Strategy, undertaken by RPS Consulting Engineers Ltd, was €129,482. A further €98,400 has been spent on a new “performance measurement framework” for “Drug and Alcohol Task Forces for the new National Drugs Strategy”. The latter was undertaken by consultancy firm Trutz Haase.
The forthcoming National Drugs Strategy will aim to “tackle the harm caused to individuals and our society by the misuse of drugs”, according to the Department. It is expected to be published before the summer.